Physiologically-Based Pharmacokinetic and Toxicokinetic Models in Cancer Risk Assessment

REFERENCES

• Wagner , J G . 1981 . History of pharmacokinetics . Pharmacol Ther , 12 : 537 – 562 . [PUBMED] [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Renwick , A G . 2003 . “ Toxicokinetics-Pharmacokinetics In Toxicology ” . In Principles and Methods of Toxicology , Edited by: Hayes , WA. 101 – 147 . New York : Raven Press .
   Google Scholar
• Clewell , H JI , Andersen , M E and Barton , H A . 2002 . A consistent approach for the application of pharmacokinetic modeling in cancer and noncancer risk assessment . Environ Health Perspect , 110 ( 1 ) : 85 – 93 . [PUBMED] [INFOTRIEVE] [CSA]
   PubMed Web of Science ®Google Scholar
• Andersen , M E and Dennison , J E . 2001 . Mode of action and tissue dosimetry in current and future risk assessments . Sci Tot Environ , 274 : 3 – 14 . [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Reitz , R H , McDougal , J N , Himmelstein , M W , Nolan , R J and Schumann , A M . 1998a . Physiologically-based pharmacokinetic modeling with methyl chloroform: Implications for interspecies, high-low dose and dose-route extrapolations . Toxicol Appl Pharmacol , 95 : 185 – 199 . [CSA] [CROSSREF]
   Google Scholar
• Reitz , R H , McCroskey , P S , Park , C N , Andersen , M E and Gargas , M L . 1990 . Development of a physiologically-based pharmacokinetic model for risk assessment with 1,4-dioxane . Toxicol Appl Pharmacol , 105 : 37 – 54 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Leung , H W and Paustenbach , D J . 1990 . Cancer risk assessment for dioxane based upon a physiologically-based pharmacokinetic modeling approach . Toxicol Lett , 51 : 147 – 162 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Andersen , M E , Clewell , H JI , Gargas , M L , Smith , F A and Reitz , R H . 1987 . Physiologically-based pharmacokinetics and risk assessment process for methylene chloride . Toxicol Appl Pharmacol , 87 : 185 – 205 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Fisher , J W and Allen , B C . 1993 . Evaluating the risk of liver cancer in humans exposed to trichloroethylene using physiological models . Risk Anal , 13 : 87 – 95 . [PUBMED] [INFOTRIEVE] [CSA]
   PubMed Web of Science ®Google Scholar
• Clewell , H JI , Gentry , P R , Gearhart , J M , Allen , B C and Andersen , M E . 2001 . Comparison of cancer risk estimates for vinyl chloride using animal and human data with a PBPK model . Sci Total Environ , 274 ( 1–3 ) : 37 – 66 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Reitz , R H , Gargas , M L , Andersen , M E , Provan , W M and Green , T L . 1996 . Predicting cancer risk from vinyl chloride exposure with a physiologically based pharmacokinetic model . Toxicol Appl Pharmacol , 137 : 253 – 267 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Gehring , P J , Watanabe , P G and Park , C N . 1978 . Resolution of dose-response toxicity data for chemicals requiring metabolic activation: example–vinyl chloride . Toxicol Appl Pharmacol , 44 ( 3 ) : 581 – 591 . [PUBMED] [INFOTRIEVE] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Haggard , H W . 1924 . The absorption, distribution and elimination of ethyl ether. Analysis of the mechanism of the absorption and elimination of such a gas or vapor as ethyl ether . J Biol Chem , 59 : 753 – 770 .
   Google Scholar
• Kety , S S . 1951 . The theory and application of the exchange of inert gas at the lungs . Pharmacol Rev , 3 : 1 – 41 . [PUBMED] [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Mapleson , W W . 1963 . An electric analog for uptake and elimination in man . J Appl Physiol , 18 : 197 – 204 . [PUBMED] [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Fiserova-Bergerova , V . 1975 . Mathematical modeling of inhalation exposure . J Combustion Toxicol , 32 : 201 – 210 .
   Google Scholar
• Krishnan , K and Andersen , M E . 2001 . “ Physiologically-based pharmacokinetic modeling in toxicology ” . In Principles and Methods of Toxicology , Edited by: Hayes , A. W. 193 – 241 . Philadelphia, PA : Taylor & Francis .
   Google Scholar
• Clewell , H JI and Andersen , M E . 1987 . Dose, species and route extrapolation using physiologically-based pharmacokinetic models . Drinking Water and Health , 8 : 159 – 182 .
   Google Scholar
• Andersen , M E , Krewski , D and Withey , J R . 1993 . Physiological pharmacokinetics and cancer risk assessment . Cancer Lett , 69 : 1 – 14 . [PUBMED] [INFOTRIEVE] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Andersen , M E and Krishnan , K . 1994 . Physiologically based pharmacokinetics and cancer risk assessment . Environ Health Perspect , 102 : 103 – 108 . (Suppl 1)[PUBMED] [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Melnick , R L and Kohn , M C . 2000 . Dose-response analyses of experimental cancer data . Drug Metab Rev , 32 : 193 – 209 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• US EPA . 2003 . Guidelines for Carcinogen Risk Assessment, Final Draft , Washington, , US : Environmental Protection Agency, Office of Research and Development . NCEA-F-0644
   Google Scholar
• Tardif , R , Charest-Tardif , G , Brodeur , J and Krishnan , K . 1997 . Physiologically-based pharmacokinetic modeling of a ternary mixture of alkyl benzenes in rats and humans . Toxicol Appl Pharmacol , 144 : 120 – 134 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Jarabek , A M , Fisher , J W , Rubenstein , R , Lipscomb , J C , Wills , R J , Vinegar , A and McDougal , J N . 1994 . Mechanistic insights aid the search for CFC Substitutes: Risk assessment of HCFC-123 as an example . Risk Analysis , 14 : 231 – 250 . [PUBMED] [INFOTRIEVE] [CSA]
   PubMed Web of Science ®Google Scholar
• Gerrity , T R , Henry , C J and Birnbaum , L . 1990 . Principles of Route-to-Route extrapolation for risk assessment , New York : Elsevier .
   Google Scholar
• Krishnan , K and Andersen , M E . 1991 . “ Physiological modeling and cancer risk assessment ” . In New Trends in Pharmacokinetics , Edited by: Rescingo , A and Thakkur , A . 335 – 354 . NY : Plenum Press .
   Google Scholar
• Kirman , C R , Hays , S M , Kedderis , G L , Gargas , M L and Strother , D E . 2000 . Improving cancer dose-response characterization by using physiologically based pharmacokinetic modeling: an analysis of pooled data for acrylonitrile-induced brain tumors to assess cancer potency in the rat . Risk Anal , 20 ( 1 ) : 135 – 151 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Poet , T S , Soelberg , J J , Weitz , K K , Mast , T J , Miller , A A , Thrall , B D and Corley , R A . 2003 . Mode of action and pharmacokinetic studies of 2-butoxyethanol in the mouse with an emphasis on forestomach dosimetry . Toxicol Sci , 71 : 176 – 189 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Reitz , R H , Mandrela , A L , Corley , R A , Quast , J F , Gargas , M L , Andersen , M E , Staats , D A and Conolly , R B . 1990 . Estimating the risk of liver cancer associated with human exposures to chloroform using physiologically-based pharmacokinetic modeling . Toxicol Appl Pharmacol , 105 : 443 – 459 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Meek , M E , Beauchamp , R , Long , G , Turner , L and Walker , M . 2002 . Chloroform: Exposure estimation, hazard characterization, and exposure-response Analysis . J Toxicol Environ Health , 5 ( B ) : 283 – 334 .
   Google Scholar
• Casanova , M , Conolly , R B and Heck , H A . 1996 . DNA-protein cross-links (DPX) and cell proliferation in B6C3F1 mice but not Syrian golden hamsters exposed to dichloromethane: Pharmacokinetics and risk assessment with DPX as dosimeter . Fund Appl Toxicol , 31 : 103 – 116 . [CSA] [CROSSREF]
   PubMedGoogle Scholar
• Schlosser , P M , Patrick , D L , Conolly , R B , Janszen , D B and Kimbell , J S . 2003 . Benchmark dose risk assessment for formaldehyde using airflow modeling and a single-compartment, DNA-protein cross-link dosimetry model to estimate human equivalent doses . Risk Analysis , 23 : 473 – 487 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Andersen , M E , Sarangapani , R , Gentry , P R , Clewell , H J III , Covington , TR and Frederick , C B . 1999 . Application of a hybrid CFD-PBPK nasal dosimetry model in an inhalation risk assessment: an example with acrylic acid . Toxicol Sci , 57 : 312 – 325 . [CSA] [CROSSREF]
   Web of Science ®Google Scholar
• Andersen , M E , Green , T , Frederick , C B and Bogdanffy , M S . 2002 . Physiologically based pharmacokinetic (PBPK) models for nasal tissue dosimetry of organic esters: assessing the state-of-knowledge and risk assessment applications with methyl methacrylate and vinyl acetate . Regul Toxicol Pharmacol , 36 : 234 – 245 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Cruzen , G , Carlson , G P , Johnson , K A , Andrews , L S , Banton , M I , Bevan , C and Cushman , J R . 2002 . Styrene respiratory tract toxicity and mouse lung tumors are mediated by CYP2F-generated metabolites . Reg Toxicol Pharmacol , 35 : 308 – 319 . [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Bogdanffy , M S , Sarangapani , R , Plowchalk , D R , Jarabek , A M and Andersen , M E . 1999 . A biologically-based risk assessment for vinyl acetate-induced cancer and noncancer inhalation toxicity . Toxicol Sci , 51 : 19 – 35 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Bogdanfy , M S , Plowchalk , D R , Sarangapani , R , Starr , T B and Andersen , M E . 2001 . Mode-of-action-based dosimeters for interspecies extrapolation on vinyl acetate inhalation risk . Inhal Toxicol , 13 : 377 – 396 . [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Reitz , R H , Mandrela , A L , Park , C N , Andersen , M E and Guengerich , F P . 1988 . Incorporation of in vitro enzyme data into the physiologically-based pharmacokinetic (PBPK) model for methylene chloride: Implications for risk assessment . Toxicol Lett , 43 : 97 – 116 . [PUBMED] [INFOTRIEVE] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Spear , R C and Bois , F Y . 1994 . Parameter variability and the interpretation of physiologically based pharmacokinetic modeling results . Environ Health Perspect , 102 : 61 – 66 . (Suppl.11)[PUBMED] [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Bois , F Y , Jackson , E T , Pekari , K and Smith , M T . 1996 . Population toxicokinetics of benzene . Environ Health Perspect , 104 : 1405 – 1411 . (Suppl.6)[PUBMED] [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Bernillon , P and Bois , F Y . 2000 . Statistical issues in toxicokinetic modeling: a Bayesian perspective . Environ. Health Perspect Suppl , 108 : S883 – S893 .
   PubMed Web of Science ®Google Scholar
• Jonsson , F and Johanson , G . 2001 . A Bayesian analysis of the influence of GSTT1 polymorphism on the cancer risk estimate for dichloromethane . Toxicol Appl Pharmacol , 174 : 99 – 112 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Jonsson , F and Johanson , G . 2002 . Physiologically-based modeling of the inhalation kinetics of styrene in humans using a Bayesian population approach . Toxicol Appl Pharmacol , 179 ( 1 ) : 35 – 49 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Wakefield , J C and Smith , A FM . 1994 . Bayesian analysis of linear and non-linear population models by using the Gibbs sample . Appl Stat , 43 : 201 – 221 .
   Web of Science ®Google Scholar
• Jonsson , F and Johanson , G . 2003 . The Bayesian population approach to physiological toxicokinetic - toxicodynamic models - an example using the MCSim software . Toxicol Lett , : 143 – 150 . [CROSSREF]
   PubMed Web of Science ®Google Scholar
• El-Masri , H A , Bell , D A and Portier , C J . 1999 . Effects of glutathione transferase theta polymorphism on the risk estimates of dichloromethane to humans . Toxicol Appl Pharmacol , 158 : 221 – 230 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ginsberg , G L . 2003 . Assessing cancer risks from short-term exposures in children . Risk Anal , 23 ( 1 ) : 19 – 34 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Gladtke , E . 1973 . Pharmacokinetics in relation to age . Boll Chim Farm , 112 : 333 – 341 . [PUBMED] [INFOTRIEVE]
   PubMedGoogle Scholar
• Ginsberg , G , Hattis , D , Sonawane , B , Russ , A , Banati , P , Kozlak , M , Smolenski , S and Goble , R . 2002 . Evaluation of child/adult pharmacokinetic differences from a database derived from the therapeutic drug literature . Toxicol Sci , 66 : 185 – 200 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Clewell , H JI , Teeguarden , J G , McDonald , T , Sarangapani , R , Lawrence , G S , Covington , T R , Gentry , R and Shipp , A. 2002 . Review and evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry . Crit Rev Toxicol , 32 ( 5 ) : 329 – 389 . [PUBMED] [INFOTRIEVE] [CSA]
   PubMed Web of Science ®Google Scholar
• Haddad , S , Restieri , C and Krishnan , K . 2001 . Characterization of age-related changes in body weight and organ weights from birth to adolescence in humans . J Toxicol Environ Health , 64 ( A ) : 453 – 464 . [CROSSREF]
   Google Scholar
• Alcorn , J and McNamara , P J . 2003 . Pharmacokinetics in the newborn . Adv Drug Delivery Rev , 55 : 667 – 686 . [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Strolin Benedetti , M and Baltes , E L . 2003 . Drug metabolism and disposition in children . Fund Clin Pharmacol , 17 : 281 – 299 . [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Price , K , Haddad , S and Krishnan , K . 2003 . Physiological modeling of age-specific changes in the pharmacokinetics of organic chemicals in children . J Toxicol Environ Health , 66 : 417 – 433 . (Part A)[CROSSREF]
   PubMed Web of Science ®Google Scholar
• Zwart , L L De , Haenen , HEMG , Versantvoort , C HM , Wolterink , G and Van Engelen , J GM . 2004 . Sips AJAM. Role of biokinetics in risk Assessment of drugs and chemicals in children . Regul Toxicol Pharmacol , 39 ( 3 ) : 282 – 309 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Clewell , H J , Gentry , P R , Covington , T R , Sarangapani , R and Teeguarden , J G . 2004 . Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry . Toxicol Sci , 79 : 381 – 393 . [PUBMED] [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Ginsberg , G , Hattis , D , Russ , A and Sonawane , B . 2004 . Physiologically based pharmacokinetic (PBPK) modeling of caffeine and theophylline in neonates and adults: Implications for assessing children's risks from environmental agents . J Toxicol Environ Health Part A , 67 : 297 – 329 . [CSA]
   PubMed Web of Science ®Google Scholar
• Hattis , D , Ginsberg , G , Sonawane , B , Smolenski , S , Russ , A , Kozlak , M and Goble , R . 2003 . Differences in pharmacokinetics between children and adults - II . Children's variability in drug elimination half-lives and in some parameters needed for physiologically-based pharmacokinetic modeling. Risk Anal , 23 : 117 – 142 . [CSA]
   Google Scholar
• Woo , Y-T , Carlo , F J Di , Arcos , J C , Argus , M F , Polansky , G and Du Bose , J . 1994 . Assessment of carcinogenic hazard of chemical mixtures through analysis of binary chemical interaction data . Environ Health Perspect , 102 : 113 – 118 . (Suppl. 9)[PUBMED] [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• U.S. EPA. Supplemental guidance for conducting health risk assessment of chemical mixtures . 2000 . Risk Assessment Forum, US E.P.A. Washington, DC
   Google Scholar
• Krishnan , K , Clewell , H JI and Andersen , M E . 1994 . Physiologically based pharmacokinetic analysis of simple mixtures . Environ Health Perspectives , 102 : 151 – 155 . [CSA]
   PubMed Web of Science ®Google Scholar
• Yang , R SH , El-Masri , H A , Thomas , R S and Constan , A A . 1995 . The use of physiologically-based pharmacokinetic pharmacodynamic dosimetry models for chemical mixtures . Toxicol Lett , : 82 – 83 . 497–504
   Web of Science ®Google Scholar
• Simmons , J E . 1996 . Application of physiologically based pharmacokinetic modelling to combination toxicology . Food Chem Toxicol , 34 ( 11–12 ) : 1067 – 1073 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Dobrev , I D , Andersen , M E and Yang , R S . 2002 . In silico toxicology: simulating interaction thresholds for human exposure to mixtures of trichloroethylene, tetrachloroethylene, and 1,1,1-trichloroethane . Environ Health Perspect , 110 ( 10 ) : 1031 – 1039 . [PUBMED] [INFOTRIEVE] [CSA]
   PubMed Web of Science ®Google Scholar
• Haddad , S , Tardif , R , Charest-Tardif , G and Krishnan , K . 1999 . Physiological modeling of the toxicokinetic interactions in a quaternary mixture of aromatic hydrocarbons . Toxicol Appl Pharmacol , 161 ( 3 ) : 249 – 257 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Haddad , S , Charest-Tardif , G , Tardif , R and Krishnan , K . 2000 . Validation of a physiological modeling framework for simulating the toxicokinetics of chemicals in mixtures . Toxicol Appl Pharmacol , 167 : 199 – 209 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Haddad , S , Beliveau , M , Tardif , R and Krishnan , K . 2001 . A PBPK modeling-based approach to account for interactions in the health risk assessment of chemical mixtures . Toxicol Sci , 63 ( 1 ) : 125 – 131 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Haddad , S and Krishnan , K . 1998 . Physiological modeling of toxicokinetic interactions: Implications for mixture risk assessment . Environ Health Perspect , 106 ( Suppl. 6 ) : 1377 – 1384 . [PUBMED] [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Blancato , J N and Chiu , N . 1993 . “ Predictive modeling for uptake and tissue distribution from human exposures ” . In Safety of Water Disinfection: Balancing Chemical & Microbial Risks , Edited by: Craun , G. Washington, D.C. : ILSI Press .
   Google Scholar
• Lévesque , B , Ayotte , P , Tardif , R , Ferron , L , Gingras , S , Schlouch , E , Gingras , G , Levallois , P and Dewailly , E . 2002 . Cancer risk associated with household exposure to chloroform . J Toxicol Environ Health Part A , 65 : 489 – 502 . [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Health Canada. Trihalomethanes in drinking water. Document for public comment. Federal-Provincial-Territorial Committee on Drinking Water, Ottawa, ON. 2004. http://www.hc-sc.gc.ca/hecs-sesc/water/pdf/trihalomethanes_drinking_water.pdf
   Google Scholar
• Bogan , K T , Hall , L C , Perry , L , Fish , R , Mckone , T , Dowd , P , Patton , S E and Mallon , B . 1988 . Health risk assessment of trichloroethylene (TCE) in California drinking water , Livermore, CA : Environmental Sciences Division, Lawrence Livermore National Laboratory, University of California .
   Google Scholar
• Weisel , C P and Jo , W K . 1996 . Ingestion, Inhalation and dermal exposures to chloroform and trichloroethene from tap water . Environ Health Perspect , 104 : 48 – 51 . [PUBMED] [INFOTRIEVE] [CSA]
   PubMed Web of Science ®Google Scholar
• Lindstrom , A B and Pleil , J D . 1996 . A methodological approach for exposure assessment studies in residence using volatile organic compound-contaminated water . J Air Waste Manage Assoc , 46 ( 11 ) : 1058 – 1066 . [CSA]
   PubMed Web of Science ®Google Scholar
• Health Canada. Trichloroethylene in drinking water. Document for public comment. Federal-Provincial-Territorial Committee on Drinking Water, Ottawa, ON. 2004; http://www.hc-sc.gc.ca/hecs-sesc/water/pdf/TCE-Consultation.pdf
   Google Scholar